LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Iovance Biotherapeutics (NASDAQ: IOVA)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ IOVA Iovance Biotherapeutics
Roche Corleen M. / officer: Chief Financial Officer
08/06/2025
Buy
$2.58
300,000
$774K
300,000